CWFT partnered with Skin Analytics to implement a skin cancer pathway using DERM to build on their already award-winning teledermatology service. The service at CWFT has undergone extensive post-market surveillance and health economic modelling which continues to show enhanced efficiency and clinical value. This has driven the Trust to transition from pilot to a sustainable, standard practice – taking steps towards the first autonomous artificial intelligence pathway for skin cancer, globally.